Download Friedrich Miescher Institute for Biomedical Research (FMI)

Published on Novartis (https://www.novartis.com)
Home > Printer-friendly PDF > R&D Locations
R&D Locations
[1]
Scientific research drives innovation at Novartis. Our researchers work to push the boundaries
of science, broaden our understanding of diseases and develop novel products with
significant benefits for patients. We are focusing on faulty molecular pathways and therapeutic
areas where we see the greatest unmet medical need and believe the scientific tools to
address these needs are within reach.
The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.
More than 6 000 scientists and physicians prioritize work based on areas of greatest patient
need and scientific understanding of disease.
Strategic alliances with academia and other companies strengthen our preclinical pipeline. We
carry out research at Novartis locations and at partner institutions around the world:
Friedrich Miescher Institute for
Biomedical Research (FMI)
Basel, Switzerland
Founded in 1970, the Friedrich Miescher Institute is devoted to fundamental biomedical
research and focuses on epigenetics, growth control and neurobiology.
Learn More [2]
The Genomics Institute of the Novartis
Research Foundation (GNF)
La Jolla, California, US
Located in San Diego’s BioMedical research center, GNF is well-known for developing novel
technology to drive cutting-edge drug discovery research, identify new biological pathways
and discover mechanisms underlying human disease.
Learn More [3]
Novartis Institutes for BioMedical
Research (NIBR) – Basel
Basel, Switzerland
Co-located with our corporate world headquarters, NIBR Basel is an integral part of the
BioValley, Europe's biotechnology hub. Drug discovery here focuses on autoimmunity,
transplantation, and inflammation, as well as musculoskeletal diseases, neuroscience, and
oncology.
Learn more about NIBR [4]
Novartis Institutes for BioMedical
Research (NIBR) – Headquarters
Cambridge, Massachusetts, US
NIBR Cambridge is located in the midst of multiple renowned academic research institutions
and innovative biotech companies. The NIBR headquarters is home to research in the areas
of oncology, ophthalmology, and cardiovascular and metabolic related diseases.
Learn More about NIBR [4]
Novartis Institutes for BioMedical
Research (NIBR) – East Hanover
East Hanover, New Jersey, US
Located on the same campus as our US Pharmaceuticals Division headquarters, NIBR East
Hanover focuses on research in cardiovascular and metabolic diseases. It is also home to the
Novartis Knowledge Center (NKC) and information analysis, preclinical safety, and
metabolism and pharmacokinetics groups.
Learn More about NIBR [4]
Novartis Institutes for BioMedical
Research (NIBR) – Emeryville
Emeryville, California, US
Located in the San Francisco Bay area, the NIBR Emeryville campus focuses on early
discovery and research activities as a hub for infectious disease research, with additional
expertise in structural and biophysical chemistry, computer-aided drug design and protein
engineering across many disease areas.
Learn More about NIBR [4]
Novartis Institutes for BioMedical
Research (NIBR) – Shanghai
Shanghai, China
Novartis has an integrated biomedical Research & Development center in Shanghai’s
Zhangjiang Hi-Tech Park in the midst of an emerging cluster of innovative academic, biotech
and pharmaceutical research institutions. Research focuses on infectious causes of cancer
primarily found in Asia and includes efforts in discovery chemistry and biomarker research.
Learn More about NIBR [4]
Novartis Institute for Tropical Diseases
(NITD)
City of Singapore, Singapore
Dedicated to finding new medicines to treat neglected, infectious diseases. As a smallmolecule drug discovery research institute, it combines the drug-discovery expertise and
cutting-edge technologies of Novartis to fight infectious tropical diseases, including Dengue
Fever, Human African Trypanosomiasis and Malaria.
Learn More About NITD [5]
Pharmaceutical Development – East
Hanover
East Hanover, New Jersey, US
The development site in East Hanover, New Jersey consists of: Technical Research &
Development, Drug Regulatory Affairs, Integrated Information Sciences * Informatics, Drug
Safety & Epidemiology, Clinical & Medical Services, Modeling & Simulation, Strategic
Sourcing, Human Resources, Finance and Operations. All global franchises are represented:
Cardiovascular & Metabolism, Neuroscience & Ophthalmics, Immunology & Infectious
Diseases, Respiratory, and Mature Products.
Learn More About Pharmaceuticals [6]
Pharmaceutical Development – Basel
Basel, Switzerland
The Development site in Basel consists of: Technical Research & Development, Drug
Regulatory Affairs, Integrated INformation Sciences & Informatics, Drug Safety &
Epidemiology, Clinical & Medical Services, Modeling & Simulation, Strategic Sourcing, Human
Resources, Finance and Operations. Additionally, all franchises are represented:
Cardiovascular & Metabolism, Neuroscience & Ophthalmics, Immunology & Infectious
Diseases, Respiratory, and Mature Products.
Learn More About Pharmaceuticals [6]
Pharmaceutical Development –
Cambridge
Cambridge, Massachusetts, US
The development facilities in Cambridge, Massachusetts are mainly: Technical Research &
Development, Clinical Development, Modeling & Simulation and Biologics.
Learn More About Pharmaceuticals [6]
Pharmaceutical Development –
Changshu
Changshu, China
The Novartis site in Changshu is situated about 80 km northwest of Shanghai, near the major
city Suzhou. Development is represented in Changshu through the Chemical and Analytical
Development, a Technical Research & Development Department. The focus of the Changshu
site is on the process and analytical research and development of innovative experimental
drug substances as well as their manufacturing technologies.
Learn More About Pharmaceuticals [6]
Pharmaceutical Development –
Hyderabad
Hyderabad, India
Novartis’ Development site in India is located in Hyderabad. This Development center
consists of Medical Scientific Communication and Documentation, Electronic Data
Management, Biometrics, Technical Research and Development, Drug Regulatory Affairs,
Drug Safety and Epidemiology, and Development Informatics.
Learn More About Pharmaceuticals [6]
Pharmaceutical Development – Shanghai
Shanghai, China
Novartis has a development center in Shanghai’s Zhangjiang Hi-Tech Park. Development is
represented at the Shanghai site by all the key pillars of exploratory and confirmatory
development: Translational Sciences, Biomarker Development and Drug Metabolism and
Pharmacokinetics and Technical Research and Development.
Learn More About Pharmaceuticals [6]
Pharmaceutical Development – Tokyo
Tokyo, Japan
Novartis’ Development site in Japan is located in Nishi-Azabu, Tokyo. The Development
representation of this site consists of Translational Science, Technical Research and
Development, Clinical Development (Cardiovascular and Metabolism, Neuroscience and
Ophthalmics, Immunology and Infectious Diseases, Respiratory and Oncology), Drug Safety
and Epidemiology Drug Regulatory Affairs.
Learn More About Pharmaceuticals [6]
Source URL: https://www.novartis.com/our-work/research-development/rd-locations
Links
[1] https://www.novartis.com/our-work/research-development/rd-locations
[2] http://www.fmi.ch/
[3] http://www.gnf.org/
[4] http://www.nibr.com/
[5] http://www.nibr.com/research/developing_world/NITD/
[6] http://www.pharma.us.novartis.com/